SCHEMBL6707720

SCHEMBL6707720

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
FAAH O00519 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
AGTR1 P30556 1/20 0.34
CNR2 P34972 3/20 0.33
GRM2 Q14416 1/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
PLA2G7 Q13093 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709917 0.89 GRIK1 (0.40) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL6713707 0.89 MEN1 (0.38) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL6709020 0.87 RARA (0.35) LMNATP53PLA2G7
SCHEMBL6862764 0.86 MEN1 (0.37) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL6713424 0.85 GSK3B (0.40) KDM4ETP53PLA2G7
SCHEMBL6711762 0.85 MAP3K5 (0.41) KMT2ANPC1LMNARAB9ARXFP1
SCHEMBL6708854 0.85 KMT2A (0.42) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6710055 0.84 IRAK4 (0.41) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL6713406 0.84 NPC1 (0.41) SMN1; SMN2NPC1LMNARAB9APLA2G7
SCHEMBL6709906 0.84 GSK3B (0.37) SMN1; SMN2NPC1RAB9ARXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MEN1 4100/4885KMT2A 3181/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.